DCM
DAFNA Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09M | Sell |
543,602
-900
| -0.2% | -$8.43K | 1.41% | 20 |
|
|
2025
Q1 | $6.69M | Buy |
544,502
+2,500
| +0.5% | +$30.7K | 1.9% | 15 |
|
|
2024
Q4 | $7.17M | Buy |
542,002
+15,300
| +3% | +$202K | 1.82% | 17 |
|
|
2024
Q3 | $10.1M | Sell |
526,702
-130,372
| -20% | -$2.51M | 2.4% | 14 |
|
|
2024
Q2 | $13.5M | Sell |
657,074
-2,500
| -0.4% | -$51.3K | 3.22% | 9 |
|
|
2024
Q1 | $15.7M | Sell |
659,574
-83,000
| -11% | -$1.98M | 3.57% | 8 |
|
|
2023
Q4 | $16M | Buy |
742,574
+284,201
| +62% | +$6.14M | 3.85% | 5 |
|
|
2023
Q3 | $6.66M | Buy |
458,373
+7,500
| +2% | +$109K | 2.07% | 14 |
|
|
2023
Q2 | $9.44M | Buy |
450,873
+3,800
| +0.8% | +$79.5K | 2.58% | 13 |
|
|
2023
Q1 | $9.44M | Hold |
447,073
| – | – | 2.83% | 11 |
|
|
2022
Q4 | $11.4M | Buy |
447,073
+91,586
| +26% | +$2.33M | 3.2% | 10 |
|
|
2022
Q3 | $8.54M | Sell |
355,487
-15,500
| -4% | -$372K | 2.3% | 12 |
|
|
2022
Q2 | $7.14M | Sell |
370,987
-1,000
| -0.3% | -$19.2K | 1.95% | 15 |
|
|
2022
Q1 | $6.47M | Buy |
371,987
+75,452
| +25% | +$1.31M | 1.68% | 16 |
|
|
2021
Q4 | $6.49M | Buy |
296,535
+215,833
| +267% | +$4.72M | 1.63% | 16 |
|
|
2021
Q3 | $1.54M | Sell |
80,702
-67,000
| -45% | -$1.28M | 0.41% | 58 |
|
|
2021
Q2 | $2.54M | Buy |
147,702
+90,202
| +157% | +$1.55M | 0.53% | 42 |
|
|
2021
Q1 | $1.29M | Buy |
57,500
+47,500
| +475% | +$1.06M | 0.31% | 68 |
|
|
2020
Q4 | $222K | Sell |
10,000
-92,713
| -90% | -$2.06M | 0.07% | 72 |
|
|
2020
Q3 | $1.52M | Sell |
102,713
-257,287
| -71% | -$3.8M | 0.49% | 44 |
|
|
2020
Q2 | $5.34M | Buy |
+360,000
| New | +$5.34M | 1.54% | 20 |
|